| Patents for C07K 16 - Immunoglobulins, e.g. monoclonal or polyclonal antibodies (149,320) |
|---|
| 10/09/2001 | US6300129 Transgenic non-human animals for producing heterologous antibodies |
| 10/09/2001 | US6300127 Bone mineralization proteins, DNA, vectors, expression systems |
| 10/09/2001 | US6300104 Producing large quantities of secretory immunoglobulin a molecules by transfecting a single cell type with an immunoglobulin containing a polynucleotide encoding a secretory component; collecting, purifying supernatant |
| 10/09/2001 | US6300102 Immunogenic hybrid protein OprF-Oprl derived from Pseudomonas aeruginosa membrane proteins |
| 10/09/2001 | US6300101 An outer surface protein; diagnosis of lyme disease; vaccines |
| 10/09/2001 | US6300099 Methods for producing secreted ligand-binding fusion proteins |
| 10/09/2001 | US6300097 A polypeptide; therapy and diagnosis of bacterial infections; upper respiratory infections, toxic shock syndrome, septic arthritis and intestinal disorders |
| 10/09/2001 | US6300094 Polynucleotides encoding a novel ABC transporter |
| 10/09/2001 | US6300089 Methods and compositions for early detection and treatment of insulin dependent diabetes mellitus |
| 10/09/2001 | US6300088 The detection of an activated peptide, that is cleaved from the prostate specific antigen during activation, for cancer diagnosis; the a biological sample is obtained and the peptide is detected in the sample by immunoassay |
| 10/09/2001 | US6300085 Diagnostic method for Alzheimer's disease |
| 10/09/2001 | US6300083 Assaying D-amino acids in body fluids |
| 10/09/2001 | US6300080 Screening molecular libraries to identify lead drug compounds that modulate adhesion between lymphocytes and cadherin expressing cells by performing adhesion assays with and without one molecular library member and compare results |
| 10/09/2001 | US6300064 Protein/(poly)peptide libraries |
| 10/09/2001 | US6299883 Tarf |
| 10/09/2001 | US6299877 Used in therapy |
| 10/09/2001 | US6299876 Cytotoxic drug therapy |
| 10/09/2001 | US6299875 Methods to block IGE binding to cell surface receptors of mast cells |
| 10/09/2001 | US6299874 Administering vaccine conjugate consisting essentially of a live virus and a neutralizing factor bound to live virus; neutralizing factor is selected from the group consisting of antibodies and antibody fragments |
| 10/09/2001 | US6299869 Human interferon-epsilon: a type I interferon |
| 10/07/2001 | CA2342961A1 Immunoassay for lsd and 2-oxo-3-hydroxy-lsd |
| 10/07/2001 | CA2340936A1 Inhibitors for the formation of soluble human cd23 |
| 10/04/2001 | WO2001073094A2 Novel sperm-dna complexes for genetically modifying non-human animals |
| 10/04/2001 | WO2001073052A2 Thermophilic polymerase iii holoenzyme |
| 10/04/2001 | WO2001073049A2 33877 and 47179, human glycosyl transferase family members and uses thereof |
| 10/04/2001 | WO2001073043A2 32451, a human ubiquitin conjugating enzyme-like molecule and uses thereof |
| 10/04/2001 | WO2001073034A2 Beta-like glycoprotein hormone polypeptide and heterodimer |
| 10/04/2001 | WO2001073033A2 Anti-angiogenic and anti-tumor properties of matin and other laminin domains |
| 10/04/2001 | WO2001073032A2 Compositions and methods for the therapy and diagnosis of prostate cancer |
| 10/04/2001 | WO2001073029A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | WO2001073028A2 A p-selectin glycoprotein ligand (psgl-1) binding protein and uses therefor |
| 10/04/2001 | WO2001073025A2 Anti-angiogenic and anti-tumor properties of vascostatin and other nidogen domains |
| 10/04/2001 | WO2001073020A1 Materials and methods relating to a novel splice variant of a na+ dependent glutamate transporter |
| 10/04/2001 | WO2001073018A2 Human tap-like protein (transporter associated in antigen processing/presentation) |
| 10/04/2001 | WO2001073015A1 Identification of human gaba transporter |
| 10/04/2001 | WO2001073014A1 Human survivin interacting protein 1 (sip-1) |
| 10/04/2001 | WO2001072993A1 Tlr/cd14 binding inhibitor |
| 10/04/2001 | WO2001072977A2 Isolated human drug-metabolizing proteins, nucleic acid molecules encoding human drug-metabolizing proteins, and uses thereof |
| 10/04/2001 | WO2001072962A2 Novel prostate-specific or testis-specific nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 10/04/2001 | WO2001072846A2 Ligands directed to the non-secretory component, non-stalk region of pigr and methods of use thereof |
| 10/04/2001 | WO2001072845A1 Use of cd25 binding molecules in the treatment of inflammatory diseases of the gastro-intestinal tract |
| 10/04/2001 | WO2001072844A2 A METHOD OF PRODUCING IgG |
| 10/04/2001 | WO2001072841A2 Isolated human g-protein coupled receptors that are members of the aminergic subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | WO2001072840A2 Isolated human g-protein coupled receptors of the mas proto-oncogene subfamily, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | WO2001072839A2 Human g-protein coupled receptors |
| 10/04/2001 | WO2001072838A2 Isolated human g-protein coupled receptors, nucleic acid molecules encoding human gpcr proteins, and uses thereof |
| 10/04/2001 | WO2001072836A2 G-protein coupled receptors |
| 10/04/2001 | WO2001072834A1 Selectable marker genes |
| 10/04/2001 | WO2001072830A2 Diagnostic and medicament for analysing the cell surface proteome of tumour and inflammatory cells and for treating tumorous and inflammatory diseases, preferably using a specific chemokine receptor analysis and the chemokine receptor-ligand interaction |
| 10/04/2001 | WO2001072822A2 Genes involved in intestinal inflammatory diseases and use thereof |
| 10/04/2001 | WO2001072781A2 Human genes and expression products |
| 10/04/2001 | WO2001072780A2 Polynucleotides for diagnosing mammary gland cancer |
| 10/04/2001 | WO2001072777A2 Human transcription factors |
| 10/04/2001 | WO2001072773A2 Genes isolated from dendritic cells, gene products and methods employing the same |
| 10/04/2001 | WO2001072772A2 Calcium binding regulatory subunit |
| 10/04/2001 | WO2001072336A1 Compounds for targeting |
| 10/04/2001 | WO2001072334A2 Methods for treating disease with antibodies to cxcr3 |
| 10/04/2001 | WO2001072333A1 Methods of therapy for non-hodgkin's lymphoma using a combination_of an antibody to cd20 and interleuking-2 |
| 10/04/2001 | WO2001072332A1 Method of screening for transcriptional coregulatory proteins of transcription factors |
| 10/04/2001 | WO2001072330A2 Method for immunostimulation using binding agents for the fc rec eptor of immunoglobulin a and for cancer cells or infections antigen |
| 10/04/2001 | WO2001072325A1 Methods of blocking tissue destruction by autoreactive t cells |
| 10/04/2001 | WO2001072295A2 Compositions and methods for the therapy and diagnosis of lung cancer |
| 10/04/2001 | WO2001036638A8 Polypeptides and nucleic acids encoding same |
| 10/04/2001 | WO2001036602A3 Pak5 a member of the p21-activated kinase (pak) protein family, nucleic acids and methods related to the same |
| 10/04/2001 | WO2001035989A3 Use of anti-idiotypical antibodies as vaccines against cancer |
| 10/04/2001 | WO2001032070A3 Reagents and methods for diagnosing, imaging and treating atherosclerotic disease |
| 10/04/2001 | WO2001021784A3 Pcna-associated cell cycle proteins, compositions and methods of use |
| 10/04/2001 | WO2001021644A3 Wheat dp proteins and uses thereof |
| 10/04/2001 | WO2001021136A3 Compositions and methods for improved detection and classification of neoplasms |
| 10/04/2001 | WO2001019955A3 Lysosomal targeting pathway enzymes |
| 10/04/2001 | WO2001019862A3 Polypeptides from moraxella (branhamella) catarrhalis |
| 10/04/2001 | WO2001019394A3 Immunotherapy with substantially human polyclonal antibody preparations purified from genetically engineered birds |
| 10/04/2001 | WO2001019373A3 Methods and compositions for modulating responsiveness to corticosteroids |
| 10/04/2001 | WO2001019335A3 Composition to be administered through mucous membrane |
| 10/04/2001 | WO2001018058A3 Enhanced phage display library of human vh fragments and methods for producing same |
| 10/04/2001 | WO2001016319A3 Compositions and methods for the treatment of immune related diseases |
| 10/04/2001 | WO2001011047A3 Dna sequences isolated from human colonic epithelial cells |
| 10/04/2001 | WO2000071564A8 Isolated nucleic acids of the p-hyde family, p-hyde proteins, and methods of inducing susceptibility to induction of cell death in cancer |
| 10/04/2001 | WO2000062795A9 UTEROGLOBIN IN THE TREATMENT OF IgA MEDIATED AUTOIMMUNE DISORDERS |
| 10/04/2001 | WO2000058351A3 ZWITTERMICIN A BIOSYNTHETIC GENE FROM $i(BACILLUS CEREUS) |
| 10/04/2001 | WO2000047625A9 Humanized immunoglobulin reactive with b7 molecules and methods of treatment therewith |
| 10/04/2001 | WO2000043039A9 Vaccine-mediated treatment of neurological disorders |
| 10/04/2001 | WO2000042074A9 Anti-ccr4 antibodies and methods of use therefor |
| 10/04/2001 | WO2000039279A9 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 10/04/2001 | WO2000032634A9 Humanized antibodies to gamma-interferon |
| 10/04/2001 | WO1999055860A8 Host-encoded protein expressed on marek's disease (mdv)-infected cells and antibody thereto |
| 10/04/2001 | US20010027565 Capable of binding envelope protein of hepatitis virus; therapy and/or diagnostic tool for hepatitis infection |
| 10/04/2001 | US20010027250 Cell line derived enzyme replacement therapy for glycogen storage disease; purity; free of human immunodeficiency virus |
| 10/04/2001 | US20010027249 Chimeric antibody comprising human immunoglobin constant region and murine variable region |
| 10/04/2001 | US20010027199 Administering a Tumor Necrosis Factor-alpha inhibitor from the group of metalloproteinase inhibitors, quinolones, corticoids, thalidomide, lazaroides, pentoxyphyllines, hydroxamic and carbocyclic acids; spinal disk hernias |
| 10/04/2001 | US20010027184 Serine/threonine protein kinase (H-SGK2) |
| 10/04/2001 | US20010027175 Inhibiting tumor necrosis factor-alpha (TNF-a) for treating nerve conditions such as sciatica by administering antiinflammatory agent etanercept or infliximab |
| 10/04/2001 | US20010026932 Agonist anti-CD40 molecules, including monoclonal antibodies, which can bind to and stimulate professional and non-professional human antigen-presenting cells; may be useful as antitumor agents |
| 10/04/2001 | US20010026931 Accelerates differentiation of megakaryocytes in the presence of IL-3, and acts as a thrombopoietin, and therefore an effective medicament to various diseases involving a decrease in platelets |
| 10/04/2001 | US20010026928 Monoclonal antibodies as well as homologues, analogues, and modified and derived forms thereof, immunoglobin fab fragments, single chain antibodies; treating pathological inflammation and autoimmune diseases |
| 10/04/2001 | US20010026925 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
| 10/04/2001 | US20010026924 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
| 10/04/2001 | US20010026923 Isolated, biologically substantially pure and viable immunocopocytes and non-epithelial cells of lymphoid origin obtained from a small fecal sample |
| 10/04/2001 | US20010026801 Administering fusion proteins for reducing inflamation of neuronal tissues in humans; tumor necrosis factor inhibition |
| 10/04/2001 | US20010026798 Methods of enhancing activity of vaccines and vaccine compositions |